American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs Journal

Publication venue for

Correction to: Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis (Nov, 10.1007/s40256-021-00511-8, 2021). 22:105-105. 2021
Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis. 22:9-26. 2021
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?. 20:413-418. 2020
COVID-19 Pandemic: Cardiovascular Complications and Future Implications. 20:311-324. 2020
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database. 18:129-141. 2018
Endovascular Stents: A Review of Their Use in Peripheral Arterial Disease. 13:199-212. 2013
Device therapy for heart failure - When and for whom?. 8:147-153. 2008

International Standard Serial Number (ISSN)

1175-3277